Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008200316> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2008200316 endingPage "S68" @default.
- W2008200316 startingPage "S65" @default.
- W2008200316 abstract "The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Guérin (BCG) for prophylaxis of recurrence of superficial bladder cancer (pTa, pT1) were investigated in 29 patients aged a median of 70 years between January of 1991 and May of 1993. The patients received intravesical instillation of 40 mg epirubicin immediately after transurethral resection (TUR) of the bladder cancer. At 1 week after TUR, 80 mg Tokyo-strain BCG was instilled into the bladder once a week for 6 weeks. Thereafter, the patients were followed by cystoscopy and urinary cytology at 3-month intervals until recurrence was detected. Of the 29 patients, 28 had no evidence of disease over a mean follow-up period of 20 months. The 1 case of recurrence occurred at 3 months after TUR and that patient died of cancer progression. The simple recurrence rate was 3.5% after therapy. According to the person-years method, the number of recurrent tumors per 100 patient-months was 0.17. The cumulative nonrecurrence rate determined for all cases was 96.5% at 30 months. Adverse reactions, including urinary frequency, urgency, and miction pain, among others, were observed in 27 patients (93%). Only 1 patient was withdrawn from the treatment because of severe bladder-irritation symptoms due to the BCG instillation. The intravesical chemoimmunotherapy with epirubicin and BCG seemed to be effective for prophylaxis of recurrence of superficial bladder cancer." @default.
- W2008200316 created "2016-06-24" @default.
- W2008200316 creator A5008866653 @default.
- W2008200316 creator A5008992972 @default.
- W2008200316 creator A5034349158 @default.
- W2008200316 creator A5087583441 @default.
- W2008200316 date "1994-01-01" @default.
- W2008200316 modified "2023-09-27" @default.
- W2008200316 title "The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Gu�rin for prophylaxis of recurrence of superficial bladder cancer: a preliminary report" @default.
- W2008200316 cites W1557955453 @default.
- W2008200316 cites W2053913462 @default.
- W2008200316 cites W2075008733 @default.
- W2008200316 cites W2337009854 @default.
- W2008200316 cites W2396442774 @default.
- W2008200316 cites W2397591042 @default.
- W2008200316 cites W2417506756 @default.
- W2008200316 cites W2418562667 @default.
- W2008200316 cites W2419184741 @default.
- W2008200316 cites W2471659321 @default.
- W2008200316 cites W2472545738 @default.
- W2008200316 cites W3468639 @default.
- W2008200316 cites W4317676586 @default.
- W2008200316 doi "https://doi.org/10.1007/bf00686923" @default.
- W2008200316 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7994790" @default.
- W2008200316 hasPublicationYear "1994" @default.
- W2008200316 type Work @default.
- W2008200316 sameAs 2008200316 @default.
- W2008200316 citedByCount "18" @default.
- W2008200316 countsByYear W20082003162013 @default.
- W2008200316 countsByYear W20082003162020 @default.
- W2008200316 countsByYear W20082003162023 @default.
- W2008200316 crossrefType "journal-article" @default.
- W2008200316 hasAuthorship W2008200316A5008866653 @default.
- W2008200316 hasAuthorship W2008200316A5008992972 @default.
- W2008200316 hasAuthorship W2008200316A5034349158 @default.
- W2008200316 hasAuthorship W2008200316A5087583441 @default.
- W2008200316 hasConcept C121608353 @default.
- W2008200316 hasConcept C126322002 @default.
- W2008200316 hasConcept C126894567 @default.
- W2008200316 hasConcept C141071460 @default.
- W2008200316 hasConcept C2776694085 @default.
- W2008200316 hasConcept C2776755627 @default.
- W2008200316 hasConcept C2778769751 @default.
- W2008200316 hasConcept C2779762690 @default.
- W2008200316 hasConcept C2780352672 @default.
- W2008200316 hasConcept C2780790343 @default.
- W2008200316 hasConcept C2780835546 @default.
- W2008200316 hasConcept C71924100 @default.
- W2008200316 hasConcept C77411442 @default.
- W2008200316 hasConceptScore W2008200316C121608353 @default.
- W2008200316 hasConceptScore W2008200316C126322002 @default.
- W2008200316 hasConceptScore W2008200316C126894567 @default.
- W2008200316 hasConceptScore W2008200316C141071460 @default.
- W2008200316 hasConceptScore W2008200316C2776694085 @default.
- W2008200316 hasConceptScore W2008200316C2776755627 @default.
- W2008200316 hasConceptScore W2008200316C2778769751 @default.
- W2008200316 hasConceptScore W2008200316C2779762690 @default.
- W2008200316 hasConceptScore W2008200316C2780352672 @default.
- W2008200316 hasConceptScore W2008200316C2780790343 @default.
- W2008200316 hasConceptScore W2008200316C2780835546 @default.
- W2008200316 hasConceptScore W2008200316C71924100 @default.
- W2008200316 hasConceptScore W2008200316C77411442 @default.
- W2008200316 hasIssue "S1" @default.
- W2008200316 hasLocation W20082003161 @default.
- W2008200316 hasLocation W20082003162 @default.
- W2008200316 hasOpenAccess W2008200316 @default.
- W2008200316 hasPrimaryLocation W20082003161 @default.
- W2008200316 hasRelatedWork W1976830962 @default.
- W2008200316 hasRelatedWork W2064952716 @default.
- W2008200316 hasRelatedWork W2085161087 @default.
- W2008200316 hasRelatedWork W2120561004 @default.
- W2008200316 hasRelatedWork W2138050084 @default.
- W2008200316 hasRelatedWork W2370208313 @default.
- W2008200316 hasRelatedWork W2433727248 @default.
- W2008200316 hasRelatedWork W2735230849 @default.
- W2008200316 hasRelatedWork W324577642 @default.
- W2008200316 hasRelatedWork W2118673085 @default.
- W2008200316 hasVolume "35" @default.
- W2008200316 isParatext "false" @default.
- W2008200316 isRetracted "false" @default.
- W2008200316 magId "2008200316" @default.
- W2008200316 workType "article" @default.